|
CDKN1A |
cyclin dependent kinase inhibitor 1A |
- SCF(Skp2)-mediated degradation of p27/p21
- AKT phosphorylates targets in the cytosol
- Senescence-Associated Secretory Phenotype (SASP)
- DNA Damage/Telomere Stress Induced Senescence
- Constitutive Signaling by AKT1 E17K in Cancer
- Interleukin-4 and Interleukin-13 signaling
- TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
- Cyclin E associated events during G1/S transition
- Cyclin D associated events in G1
- p53-Dependent G1 DNA Damage Response
- Cyclin A:Cdk2-associated events at S phase entry
- Transcriptional activation of cell cycle inhibitor p21
- The role of GTSE1 in G2/M progression after G2 checkpoint
- TFAP2 (AP-2) family regulates transcription of cell cycle factors
- Transcriptional regulation by RUNX2
- RUNX3 regulates CDKN1A transcription
- Neddylation
- Transcriptional regulation of granulopoiesis
- FOXO-mediated transcription of cell cycle genes
- Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
- STAT5 activation downstream of FLT3 ITD mutants
- Signaling by FLT3 fusion proteins
- Signaling by ALK fusions and activated point mutants
- KEAP1-NFE2L2 pathway
- Regulation of MITF-M-dependent genes involved in cell cycle and proliferation
|
- Valproic acid
- Arsenic trioxide
|
|
|
CDKN2C |
cyclin dependent kinase inhibitor 2C |
- Oxidative Stress Induced Senescence
- Senescence-Associated Secretory Phenotype (SASP)
- Oncogene Induced Senescence
- Cyclin D associated events in G1
|
|
|
|
CFAP77 |
cilia and flagella associated protein 77 |
|
|
|
|
CHAF1A |
chromatin assembly factor 1 subunit A |
|
|
|
|
CHCHD2 |
coiled-coil-helix-coiled-coil-helix domain containing 2 |
- Mitochondrial protein import
- Mitochondrial protein degradation
|
|
|
|
CHIC2 |
cysteine rich hydrophobic domain 2 |
|
|
|
|
CKS1B |
CDC28 protein kinase regulatory subunit 1B |
- SCF(Skp2)-mediated degradation of p27/p21
- Cyclin D associated events in G1
|
- Fluoxetine
- 2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium
|
|
|
CLCNKA |
chloride voltage-gated channel Ka |
|
- Niflumic acid
- Talniflumate
|
|
|
COA5 |
cytochrome c oxidase assembly factor 5 |
|
|
- Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
|
|
CPNE2 |
copine 2 |
|
|
|
|
CTBP1 |
C-terminal binding protein 1 |
- Deactivation of the beta-catenin transactivating complex
- SUMOylation of transcription cofactors
- Repression of WNT target genes
- Signaling by TCF7L2 mutants
- Negative Regulation of CDH1 Gene Transcription
|
|
|
|
CTNNB1 |
catenin beta 1 |
- Degradation of beta-catenin by the destruction complex
- Beta-catenin phosphorylation cascade
- TCF dependent signaling in response to WNT
- Formation of the beta-catenin:TCF transactivating complex
- Formation of the beta-catenin:TCF transactivating complex
- LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
- Apoptotic cleavage of cell adhesion proteins
- Deactivation of the beta-catenin transactivating complex
- Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)
- Ca2+ pathway
- Adherens junctions interactions
- Binding of TCF/LEF:CTNNB1 to target gene promoters
- Disassembly of the destruction complex and recruitment of AXIN to the membrane
- Disassembly of the destruction complex and recruitment of AXIN to the membrane
- VEGFR2 mediated vascular permeability
- Myogenesis
- Myogenesis
- Signaling by GSK3beta mutants
- CTNNB1 S33 mutants aren't phosphorylated
- CTNNB1 S37 mutants aren't phosphorylated
- CTNNB1 S45 mutants aren't phosphorylated
- CTNNB1 T41 mutants aren't phosphorylated
- RHO GTPases activate IQGAPs
- Transcriptional Regulation by VENTX
- InlA-mediated entry of Listeria monocytogenes into host cells
- RUNX3 regulates WNT signaling
- Cardiogenesis
- Germ layer formation at gastrulation
- Regulation of CDH11 function
- Regulation of CDH11 function
- Regulation of CDH19 Expression and Function
- Regulation of CDH1 Function
- Degradation of CDH1
- Regulation of CDH1 posttranslational processing and trafficking to plasma membrane
- Formation of paraxial mesoderm
- Formation of axial mesoderm
- Formation of definitive endoderm
- Somitogenesis
- Regulation of MITF-M-dependent genes involved in pigmentation
- Regulation of MITF-M-dependent genes involved in cell cycle and proliferation
- Formation of the nephric duct
- CDH11 homotypic and heterotypic interactions
- Specification of the neural plate border
- High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
- Transcriptional and post-translational regulation of MITF-M expression and activity
- Regulation of PD-L1(CD274) transcription
|
|
- Pilomatricoma; Epithelioma calcificans of Malherbe
- Gastric cancer
- Hepatocellular carcinoma
- Thyroid cancer
- Colorectal cancer
- Endometrial Cancer
|
|
DAXX |
death domain associated protein |
- SUMOylation of transcription cofactors
- Regulation of TP53 Degradation
- HCMV Early Events
- Inhibition of DNA recombination at telomere
- Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations
- Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations
|
|
|
|
DDX6 |
DEAD-box helicase 6 |
- mRNA decay by 5' to 3' exoribonuclease
|
|
|
|
DEF6 |
DEF6 guanine nucleotide exchange factor |
- RHOA GTPase cycle
- CDC42 GTPase cycle
- RAC1 GTPase cycle
- RAC2 GTPase cycle
|
|
|
|
DGCR6 |
DiGeorge syndrome critical region gene 6 |
|
|
|
|
DMRT3 |
doublesex and mab-3 related transcription factor 3 |
|
|
|
|
DNTT |
DNA nucleotidylexotransferase |
|
- 2',3'-Dideoxyadenosine triphosphate
|
|
|
DUSP23 |
dual specificity phosphatase 23 |
|
|
|
|
DUSP29 |
dual specificity phosphatase 29 |
|
|
|